CSL Names GSK Executive Deborah Waterhouse as CEO
Australian biotechnology firm CSL has appointed GSK executive Deborah Waterhouse as its new chief executive officer. Waterhouse will succeed interim leader Gordon Naylor in February to drive earnings growth following recent restructuring.
Xurve View
Insights:
Xurve View
CSL LTD-SPONSORED ADR named GSK PLC-SPON ADR executive Deborah Waterhouse as CEO and managing director, effective February. The appointment follows a months-long search after the departure of former CEO Paul McKenzie in February. Waterhouse will lead the Australia biotechnology company from the United Kingdom as it targets sustained earnings growth.
